VisCap: Inference and Visualization of Germ-line Copy-number Variants from Targeted Clinical Sequencing Data

Overview

Journal Genet Med

Publisher Elsevier

Specialty Genetics

Date 2015 Dec 19

PMID 26681316

Citations 37

Authors

Trevor J Pugh

Sami S Amr

Mark J Bowser

Sivakumar Gowrisankar

Elizabeth Hynes

Lisa M Mahanta

Heidi L Rehm

Birgit Funke

Matthew S Lebo

Affiliations

Soon will be listed here.

Abstract

Purpose: To develop and validate VisCap, a software program targeted to clinical laboratories for inference and visualization of germ-line copy-number variants (CNVs) from targeted next-generation sequencing data.

Methods: VisCap calculates the fraction of overall sequence coverage assigned to genomic intervals and computes log2 ratios of these values to the median of reference samples profiled using the same test configuration. Candidate CNVs are called when log2 ratios exceed user-defined thresholds.

Results: We optimized VisCap using 14 cases with known CNVs, followed by prospective analysis of 1,104 cases referred for diagnostic DNA sequencing. To verify calls in the prospective cohort, we used droplet digital polymerase chain reaction (PCR) to confirm 10/27 candidate CNVs and 72/72 copy-neutral genomic regions scored by VisCap. We also used a genome-wide bead array to confirm the absence of CNV calls across panels applied to 10 cases. To improve specificity, we instituted a visual scoring system that enabled experienced reviewers to differentiate true-positive from false-positive calls with minimal impact on laboratory workflow.

Conclusions: VisCap is a sensitive method for inferring CNVs from targeted sequence data from targeted gene panels. Visual scoring of data underlying CNV calls is a critical step to reduce false-positive calls for follow-up testing.Genet Med 18 7, 712-719.Genetics in Medicine (2016); 18 7, 712-719. doi:10.1038/gim.2015.156.

Citing Articles

Detection of germline CNVs from gene panel data: benchmarking the state of the art.

Munte E, Roca C, Del Valle J, Feliubadalo L, Pineda M, Gel B Brief Bioinform. 2024; 26(1).

PMID: 39668338 PMC: 11637760. DOI: 10.1093/bib/bbae645.

Understanding Parkinson disease in Spain: Genetic and clinical insights.

Gomez-Garre P, Martin-Bornez M, Munoz-Delgado L, Diaz-Belloso R, Perinan M, Bonilla-Toribio M Eur J Neurol. 2024; 32(1):e16499.

PMID: 39498811 PMC: 11622318. DOI: 10.1111/ene.16499.

and Deletion Identified by Targeted Panel Sequencing with CNV Analysis in X-Linked Ichthyosis: A Case Report and Literature Review.

Park J, Cho Y, Kim J, Kim H Genes (Basel). 2023; 14(10).

PMID: 37895274 PMC: 10606178. DOI: 10.3390/genes14101925.

Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA.

Wong D, Luo P, Oldfield L, Gong H, Brunga L, Rabinowicz R Cancer Discov. 2023; 14(1):104-119.

PMID: 37874259 PMC: 10784744. DOI: 10.1158/2159-8290.CD-23-0456.

Detection of Nine Oncogenes Amplification in Lung and Colorectal Cancer Formalin-Fixed Paraffin-Embedded Tissue Samples using Combined Next-Generation Sequencing-Based Script and Digital Droplet Polymerase Chain Reaction.

Bontoux C, Guyard A, Lupo A, Diallo K, Rebah K, Hercent A Cancer Control. 2023; 30:10732748231167257.

PMID: 37386758 PMC: 10328004. DOI: 10.1177/10732748231167257.

References

Mandelker D, Amr S, Pugh T, Gowrisankar S, Shakhbatyan R, Duffy E . Comprehensive diagnostic testing for stereocilin: an approach for analyzing medically important genes with high homology. J Mol Diagn. 2014; 16(6):639-47. DOI: 10.1016/j.jmoldx.2014.06.003. View

Love M, Mysickova A, Sun R, Kalscheuer V, Vingron M, Haas S . Modeling read counts for CNV detection in exome sequencing data. Stat Appl Genet Mol Biol. 2012; 10(1). PMC: 3517018. DOI: 10.2202/1544-6115.1732. View

Sathirapongsasuti J, Lee H, Horst B, Brunner G, Cochran A, Binder S . Exome sequencing-based copy-number variation and loss of heterozygosity detection: ExomeCNV. Bioinformatics. 2011; 27(19):2648-54. PMC: 3179661. DOI: 10.1093/bioinformatics/btr462. View

Krumm N, Sudmant P, Ko A, ORoak B, Malig M, Coe B . Copy number variation detection and genotyping from exome sequence data. Genome Res. 2012; 22(8):1525-32. PMC: 3409265. DOI: 10.1101/gr.138115.112. View

Samarakoon P, Sorte H, Kristiansen B, Skodje T, Sheng Y, Tjonnfjord G . Identification of copy number variants from exome sequence data. BMC Genomics. 2014; 15:661. PMC: 4132917. DOI: 10.1186/1471-2164-15-661. View

Krawitz P, Schiska D, Kruger U, Appelt S, Heinrich V, Parkhomchuk D . Screening for single nucleotide variants, small indels and exon deletions with a next-generation sequencing based gene panel approach for Usher syndrome. Mol Genet Genomic Med. 2014; 2(5):393-401. PMC: 4190874. DOI: 10.1002/mgg3.92. View

Abou Tayoun A, Tunkey C, Pugh T, Ross T, Shah M, Lee C . A comprehensive assay for CFTR mutational analysis using next-generation sequencing. Clin Chem. 2013; 59(10):1481-8. PMC: 4570467. DOI: 10.1373/clinchem.2013.206466. View

Hindson B, Ness K, Masquelier D, Belgrader P, Heredia N, Makarewicz A . High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem. 2011; 83(22):8604-10. PMC: 3216358. DOI: 10.1021/ac202028g. View

Fromer M, Moran J, Chambert K, Banks E, Bergen S, Ruderfer D . Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. Am J Hum Genet. 2012; 91(4):597-607. PMC: 3484655. DOI: 10.1016/j.ajhg.2012.08.005. View

10.

McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A . The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303. PMC: 2928508. DOI: 10.1101/gr.107524.110. View

11.

Li J, Lupat R, Amarasinghe K, Thompson E, Doyle M, Ryland G . CONTRA: copy number analysis for targeted resequencing. Bioinformatics. 2012; 28(10):1307-13. PMC: 3348560. DOI: 10.1093/bioinformatics/bts146. View

12.

Rehm H, Bale S, Bayrak-Toydemir P, Berg J, Brown K, Deignan J . ACMG clinical laboratory standards for next-generation sequencing. Genet Med. 2013; 15(9):733-47. PMC: 4098820. DOI: 10.1038/gim.2013.92. View

13.

Alfares A, Kelly M, McDermott G, Funke B, Lebo M, Baxter S . Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med. 2015; 17(11):880-8. DOI: 10.1038/gim.2014.205. View

14.

Frampton G, Fichtenholtz A, Otto G, Wang K, Downing S, He J . Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol. 2013; 31(11):1023-31. PMC: 5710001. DOI: 10.1038/nbt.2696. View

15.

Feng Y, Chen D, Wang G, Zhang V, Wong L . Improved molecular diagnosis by the detection of exonic deletions with target gene capture and deep sequencing. Genet Med. 2014; 17(2):99-107. PMC: 4338802. DOI: 10.1038/gim.2014.80. View

16.

Plagnol V, Curtis J, Epstein M, Mok K, Stebbings E, Grigoriadou S . A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics. 2012; 28(21):2747-54. PMC: 3476336. DOI: 10.1093/bioinformatics/bts526. View

17.

Kurian A, Hare E, Mills M, Kingham K, McPherson L, Whittemore A . Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol. 2014; 32(19):2001-9. PMC: 4067941. DOI: 10.1200/JCO.2013.53.6607. View

18.

Pugh T, Kelly M, Gowrisankar S, Hynes E, Seidman M, Baxter S . The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med. 2014; 16(8):601-8. DOI: 10.1038/gim.2013.204. View

19.

Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-60. PMC: 2705234. DOI: 10.1093/bioinformatics/btp324. View

20.

Tang W, Qian D, Ahmad S, Mattox D, Todd N, Han H . A low-cost exon capture method suitable for large-scale screening of genetic deafness by the massively-parallel sequencing approach. Genet Test Mol Biomarkers. 2012; 16(6):536-42. PMC: 3378026. DOI: 10.1089/gtmb.2011.0187. View